Cash flow from operating activities
|
In millions
|
In millions
|
|
For the year ended 2012
|
For the year ended 2011
|
Net (loss) earnings
|
$(12,650)
|
$7,074
|
Depreciation and amortization
|
5,095
|
4,984
|
Impairment of goodwill and purchased intangible assets
|
18,035
|
885
|
Stock-based compensation expense
|
635
|
685
|
Provision for doubtful accounts
|
142
|
81
|
Provision for inventory
|
277
|
217
|
Restructuring charges
|
2,266
|
645
|
Deferred taxes on earnings
|
(711)
|
166
|
Excess tax benefit from stock-based competition
|
(12)
|
(163)
|
Other, net
|
265
|
(46)
|
Accounts and financing receivables
|
1,269
|
(227)
|
Inventory
|
890
|
(1,252)
|
Accounts payable
|
(1,414)
|
275
|
Taxes on earnings
|
(320)
|
610
|
Restructuring
|
(840)
|
(1,002)
|
Other assets and liabilities
|
(2,356)
|
(293)
|
Net cash provided by operating activities
|
10,571
|
12,639
|
Cash flows from investing activities:
|
|
|
Investment in property, plant, and equipment
|
(3,706)
|
(4,539)
|
Proceeds from sale of property, plant, and equipment
|
617
|
999
|
Purchases of available-for-sale securities and other investments
|
(972)
|
(96)
|
Maturities and sales of available-for-sale securities and other investment
|
662
|
68
|
Payments in connection with business acquisitions, net of cash acquired
|
(141)
|
(10,480)
|
Proceeds from business divestiture, net
|
87
|
89
|
Net cash used in investing activities
|
(3,453)
|
(13,959)
|
Cash flow from financing activities:
|
|
|
(Payments) issuance of commercial paper and notes payable, net
|
(2,775)
|
(1,270)
|
Issuance of debt
|
5,154
|
11,942
|
Payment of debt
|
(4,333)
|
(2,336)
|
Issuance of common stock under employee stock plans
|
716
|
896
|
Repurchase of common stock
|
(1,619)
|
(10,117)
|
Excess tax benefit from stock-based compensation
|
12
|
163
|
Cash dividends paid
|
(1,015)
|
(844)
|
Net cash used in financing activities
|
(3,860)
|
(1,566)
|
Increase (decrease) in cash and cash equivalents
|
3,258
|
(2,886)
|
Cash and cash equivalents at beginning of period
|
8,043
|
10,929
|
Cash and cash equivalents at end of period
|
$11,301
|
$8,043
|